UBS analyst Erika Najarian raised the firm’s price target on Morgan Stanley (MS) to $165 from $156 and keeps a Neutral rating on the shares. Bank stocks delivered strong Q2 gains, with share price appreciation outpacing estimate revisions by roughly fivefold, driven by deregulation, improving capital markets activity, and solid loan growth, the analyst tells investors in a research note. The Fifth Third (FITB)/Comerica (CMA) merger may reignite interest in regional banks, particularly if management signals a rebound in middle-market C&I lending and NIM improvement from a steepening yield curve, though selectivity is warranted after the recent rally, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MS:
- Banks competing for roles on Fannie Mae, Freddie Mac IPOs, WSJ reports
- Crypto Currents: Bitcoin tops $125K as Morgan Stanley advisors push bitcoin ETFs
- Morgan Stanley initiated with an Outperform at BMO Capital
- ‘Strong Turnaround’? Nike Stock (NKE) Races on Q1 Beat, But Analyst Forecasts Fracture
- Morgan Stanley makes statement on Stress Capital Buffer reconsideration
